SMTL ID : 8eo2.2 (1 other biounit)

Lufaxin a bifunctional inhibitor of complement and coagulation

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.31 Å

Oligo State

monomer

Ligands

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 5 residues within 4Å: Chain A: S.38, N.40, H.43, V.45, Q.80 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Q.80, A:K.90

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 8 residues within 4Å: Chain A: Y.231, N.232, G.233, E.234, C.235, N.239, C.242, E.243 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:Y.231 Hydrogen bonds: A:N.232, A:E.234, A:N.239, A:E.243

2 x BR: BROMIDE ION(Non-covalent)

BR.3: 3 residues within 4Å: Chain A: K.117, R.185, E.186 Ligand excluded by PLIP BR.4: 4 residues within 4Å: Chain A: S.115, F.116, D.118, R.119 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Andersen, J.F. et al., A bispecific inhibitor of complement and coagulation blocks activation in complementopathy models via a novel mechanism. Blood (2023)

Release Date

2023-08-09

Peptides

Lufaxin: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Lufaxin

Related Entries With Identical Sequence